FindTrial
Sign In

Significance of CA-125 in different body fluids in women with endometriosis

CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - CA-125

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038441
Enrollment
60
Registered
2021-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N801- Endometriosis of ovary

Interventions

Control Intervention1: NIL: NIL

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women between 18-65 years of age with endometriosis planned for surgical management laparotomy/ Laparoscopy for endometriosis

Exclusion criteria

Exclusion criteria: Women with active diagnosed malignancy or for conservative management of endometriosis or with active pelvic infection

Design outcomes

Primary

MeasureTime frame
To evaluate CA-125 in serum and peritoneal fluid (PF) as an indicator of superficial and deep endometriosisTimepoint: Baseline—

Secondary

MeasureTime frame
To establish the positive correlation between serum and peritoneal CA125 levels in women with pelvic endometriosis. Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Vaishnavi

Kasturba Medical College

rex2000@rediffmail.com9986143120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026